Clinical trial
A Randomized, Double Blinded, Multi-center Phase III Confirmatory Study to Assess the Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over
NCT03120364 is registered in ClinicalTrials.gov with SK Chemicals Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double Blinded, Multi-center Phase III Confirmatory Study to Assess the Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over
- Lead sponsor
- SK Chemicals Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 9, 2015
- Completion date
- April 28, 2016
- Enrollment
- 824 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.